Vaccinex (VCNX) Tops Q1 EPS by 20c

Vaccinex (NASDAQ: VCNX) reported Q1 EPS of ($0.10), $0.20 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $550 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue
• Sony to end PlayStation disc production in January 2028